Home | Structured Search | Drug Resource
Find: within
Carbon Monoxide Poisoning > Diagnosis Author: Jeffrey T. Chapman, MD
Editorial changes - 2009-10-30
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • The diverse symptoms testify to the ubiquity of CO-binding proteins and the dependence on oxygen utilization within all cells.
  • Housemates frequently have symptoms similar to the index case because of common exposure.

Evidence:

  • Three recent expert reviews describe that acute CO intoxication manifests with variable symptoms (16), but most relate to neurologic (17) or cardiopulmonary dysfunction (18).
  • The mechanism of organ dysfunction is from decreased oxygen delivery and even more importantly impairment of intracellular cytochromes as noted in a recent review (19).
  • An observational study noted that of 89 patients presenting with a flu-like illness in the winter months, the 4 with CO poisoning had a similarly affected housemate and heated with an alternative indoor fuel source (20).

Comments:

  • Adult hemoglobin binds CO with high affinity, approximately 200 to 250 times stronger than oxygen. Elevated blood CO levels displace oxygen from hemoglobin and left shift the oxygen-hemoglobin dissociation curve, both of which cause decreased delivery of oxygen to tissue.
  • In addition, elevated intracellular levels of CO cause mitochondrial and other types of cell dysfunction through CO binding of cytochromes. This is an important concept and explains why end-organ dysfunction persists despite normalization of tissue oxygen delivery.
  • Neurologic and cardiopulmonary function are most frequently impaired because of the fixed energy requirements of these organs.

FAQs
Jeffrey T. Chapman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.